Latest Stock Split Details
Key information about Statera Biopharma, Inc.'s most recent stock split
Split Date: 2015-01-28
Split Ratio: 1:20
Price Before Split: N/A
Price After Split: N/A
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 20.00 times fewer shares (a 1:20 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Statera Biopharma, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2015-01-28 | 1:20 | Yes | N/A | N/A |
About Statera Biopharma, Inc.
Company overview and industry information
Statera Biopharma, Inc. (STAB) operates in the Biotechnology industry. The recent 1-for-20 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Statera Biopharma, Inc. Summary